<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01546506</url>
  </required_header>
  <id_info>
    <org_study_id>2010.654/58</org_study_id>
    <nct_id>NCT01546506</nct_id>
  </id_info>
  <brief_title>Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells</brief_title>
  <acronym>FLUMED</acronym>
  <official_title>Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale:

      Classical antiviral therapies target viral proteins and are consequently subject to
      resistance. To counteract this limitation, alternative strategies have been developed that
      target cellular factors. We hypothesized that such an approach could also be useful to
      identify broad-spectrum antivirals. The influenza A virus was used as a model for its viral
      diversity and because of the need to develop therapies against unpredictable viruses as
      recently underlined by the H1N1 pandemic. Gene-expression signature-based screening
      identified broadly effective influenza A antivirals. Midodrine showed great results in
      inhibiting viral growth and was the most suited to confirm its efficacy in vivo.

      The main objective of the study is to assess the efficacy of midodrine taken at usual
      recommended dose (7.5mg/day) versus no treatment on viral replication kinetics of virus
      Influenza A.

      Secondary objectives: evaluation of the number of patients with a normalized viral load 2, 3
      5 and 7 days post-treatment; description of the anti-viral efficacy of midodrine defined as
      the delay to obtain a prolonged negativity of viral RNA; description of the tolerance of
      midodrine, evaluation of the clinical response to study treatment; evaluation of the dynamic
      of viral replication; analysis of the frequency of emergence of mutants and associated
      resistance.

      Methods:

      This is a multicenter, randomized, open-label study comparing patients aged 18 to 65 years
      infected by influenza A virus. Nasopharyngeal washing will be performed at day 0
      (randomization), 2, 3, 5 to show the viral replication evolution.

      161 patients will be randomized as follows :

        -  Arm 1 : Midodrine, 2.5 mg, 3 times a day

        -  Arm 2 : No treatment The recruitment is performed by general practitioners in the Lyon
           area.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of viral replication kinetics between the 2 arms</measure>
    <time_frame>7 days</time_frame>
    <description>Comparison of the viral load slopes for 7 days post-study treatment start. Viral load will be measured at day 0, 2, 3, 5, and 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with a normalized viral load</measure>
    <time_frame>7 days</time_frame>
    <description>A normal viral load is defined as a value below the positive threshold of 3 in RT-qPCR at day 2, 3, 5 and 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration and severity of flu symptoms</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency, duration and level of replication of the virus in nose samples</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Viral resistance and decrease of sensitivity of collected strains</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of midodrine : incidence of adverse effects</measure>
    <time_frame>7 days</time_frame>
    <description>Side effects will be checked at each visit and reported for the entire study timeframe.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Influenza A Virus Infection</condition>
  <arm_group>
    <arm_group_label>Midodrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Midodrine 2.5 mg orally 3 times daily, 5 day-treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gutron® treatment</intervention_name>
    <description>Midodrine 2.5 mg orally 3 times daily, 5 day-treatment.</description>
    <arm_group_label>Midodrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women aged 18 to 65 years,

          -  with no long-term illness,

          -  presenting flu-like symptoms for less than 42 hours (nasal congestion, sore throat,
             muscle soreness, asthenia, headache, chills/sweating, fever…),

          -  infection with influenza A virus confirmed with a quick diagnostic test,

          -  outpatient care,

          -  must provide signed and informed consent,

          -  beneficiary of a health insurance.

        Exclusion Criteria:

          -  severe form of flu,

          -  pregnant women or positive pregnancy test,

          -  breastfeeding women,

          -  women of childbearing-potential with no efficient contraceptive,

          -  history of chronic respiratory disease : asthma or chronic obstructive pulmonary
             disease,

          -  renal failure,

          -  Raynaud's disease,

          -  history of epilepsy, confusion, hallucinations or of psychoneurotic state,

          -  patients with an increased cardiovascular risk (&gt; 20% according to the Framingham
             scale) or with a cardiovascular history,

          -  patients having a congestive heart failure, swollen legs or a posture hypotension,

          -  patients who received a influenza vaccine for seasons 2011-2012 or 2012-2013,

          -  known hypersensitivity to any component of the treatment,

          -  topical use of nasal decongestant (except physiological serum),

          -  use of steroids, immunosuppressive or antipsychotics drugs (including treatments for
             nausea),

          -  use of indirect sympathomimetics drugs (ephedrine, methylphenidate, phenylephrine,
             pseudoephedrine),

          -  use of dopaminergic ergot alkaloids (bromocriptine, cabergoline, lisuride, pergolide)
             or vasoconstrictor ergot alkaloids (dihydroergotamine, ergotamine, methylergométrine,
             methylsergide),

          -  known hypertension treated or not,

          -  history of bradycardia,

          -  history of urinary retention,

          -  severe cardiopathy,

          -  acute angle-closure glaucoma,

          -  severe obliterative vasculopathy,

          -  vasospasm,

          -  thyrotoxicosis,

          -  pheochromocytoma,

          -  history of angina pectoris,

          -  use of guanethidine and related, iproniazide (non selective MAOIs), alpha-blockers and
             digitalis drugs

          -  use of neuraminidase inhibitors: oseltamivir, zanamivir; and M2 proton-selective ion
             channel inhibitors: amantadine and rimantadine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno LINA, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laboratoire de virologie, Institut de microbiologie, Centre de Biologie et de Pathologie EST, Groupement Hospitalier Est, Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cabinet Médical du Dr ALIBERT</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr CURE</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre d'Investigation Clinique de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr DAHAN</name>
      <address>
        <city>Decine Charpieu</city>
        <zip>69150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr MADELON</name>
      <address>
        <city>Décine Charpieu</city>
        <zip>69150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr HILLION</name>
      <address>
        <city>Lyon</city>
        <zip>69001</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabient Médical du Dr PIOS</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr ATTALI</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr COUTY</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital D'Instruction des Armées Desgenettes</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr FORGEOIS</name>
      <address>
        <city>Lyon</city>
        <zip>69005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr TERRASSE</name>
      <address>
        <city>Lyon</city>
        <zip>69005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr THIBAUT</name>
      <address>
        <city>Lyon</city>
        <zip>69006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr BUGEL</name>
      <address>
        <city>Lyon</city>
        <zip>69006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr CHAPDANIEL</name>
      <address>
        <city>Lyon</city>
        <zip>69006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr AKIKI</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr BOURAS</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr GREVE</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr MANOELIAN</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr ROCHE</name>
      <address>
        <city>Lyon</city>
        <zip>69007</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr AZULAY TEBOUL</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr DRUT</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr SAINT-OLIVE</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr JACQUET</name>
      <address>
        <city>Meyzieu</city>
        <zip>69330</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr CHAMPETIER</name>
      <address>
        <city>Saint Priest</city>
        <zip>69800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cbinet Médical du Dr CEZANNE-BERT</name>
      <address>
        <city>Saint Priest</city>
        <zip>69800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr SMIT</name>
      <address>
        <city>Saint-priest</city>
        <zip>69800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr DUBOIS</name>
      <address>
        <city>Saint-Symphorien d'Ozon</city>
        <zip>69360</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr FARHAT</name>
      <address>
        <city>St Pierre de Chandieu</city>
        <zip>69780</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet du Dr CHAIZE</name>
      <address>
        <city>Venissieux</city>
        <zip>69200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr MARTIN</name>
      <address>
        <city>Venissieux</city>
        <zip>69200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr THEOULE</name>
      <address>
        <city>Venissieux</city>
        <zip>69200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr MOREAU</name>
      <address>
        <city>Villefontaine</city>
        <zip>38090</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr BUFFLER</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr KESSOUS</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr MONLOUBOU</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr PERDRIX</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr PILLARS</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Médical du Dr WEBER</name>
      <address>
        <city>Villeurbanne</city>
        <zip>69100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2012</study_first_submitted>
  <study_first_submitted_qc>March 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <last_update_submitted>January 7, 2015</last_update_submitted>
  <last_update_submitted_qc>January 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Virus Diseases</mesh_term>
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antiviral Agents</mesh_term>
    <mesh_term>Midodrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

